Michela Spinelli, Chief Scientific Officer

Michela Spinelli (born in 1983) is Chief Scientific Officer. She holds a PhD in Industrial Biotechnology Pharmacogenomics from the University of Milan-Bicocca (Italy) and she has 15 years’ experience in cancer academic research. From 2009 to 2010 she worked as researcher at Kimmel Cancer Center, Department of Urology (Philadelphia, USA). From 2010 to 2011 she Read more about Michela Spinelli, Chief Scientific Officer[…]

Antonio Francesco Di Naro, PRESIDENT

Antonio Francesco Di Naro (born in 1966) is President. He holds a doctor in chemistry and pharmaceutical technologies and developed two transplantation products (Thymoglobuline and Celsior). He has more than 20 years’ experience in the development of orphan drugs from reasearch to commercialization. He began his career as a teacher at vocational schools of Bergamo Read more about <p hidden>1</p>Antonio Francesco Di Naro, PRESIDENT[…]

Enrico Paroni, General Manager ADIENNE Pharma & Biotech (Switzerland)

Enrico Paroni (born in 1977) is ADIENNE Pharma & Biotech General Manager. He holds a doctor in chemistry and pharmaceutical technologies. He has more than 15 years’ experience in the formulation, process development and manufacturing of liquid and lyophilized injectable products. He began his carrier in 2003 at AstraZeneca (Italy) where he covered several positions Read more about Enrico Paroni, General Manager ADIENNE Pharma & Biotech (Switzerland)[…]

Francesc Corpas Lara, Chief Commercial Officer

Francesc Corpas Lara (born in 1969) is ADIENNE’s Chief Commercial Officer. He began his career at Parke Davis and later at Aventis Spain where he developed several projects; the latest project was developed in the area of pharmaceuticals for severe and rare diseases. He also held several executive positions at SangStat Spain SL, an US Read more about Francesc Corpas Lara, Chief Commercial Officer[…]

Marco Sardella, Chief Pharmacovigilance Officer

Marco Sardella (born in 1979) is Chief Pharmacovigilance Officer and European Qualified Person for Pharmacovigilance (EEA QPPV) of ADIENNE. In this function, he is globally responsible for the safety of products under investigation and/or available on the markets. He heads the Pharmacovigilance and Risk Management teams. He has a degree in Pharmaceutical Chemistry and Technologies Read more about Marco Sardella, Chief Pharmacovigilance Officer[…]

Silvia Nosari, Chief Regulatory Affairs Officer

Silvia Nosari (born in 1981) is ADIENNE’s Chief Regulatory Affairs Officer. She graduated from the University of Milan (Italy) in Industrial Biotechnology Pharmacogenomics. Afterwards, she joined the Milan-based Istituto Mario Negri as research scientist, conducting genetic research in the field of rare diseases. She joined the company in 2006 as R&D Manager and is heading Read more about Silvia Nosari, Chief Regulatory Affairs Officer[…]

Federico Sanvito, Chief Manufacturing Officer and General Manager ADIENNE SRL (Italy)

Federico Sanvito (born in 1966) is Chief Manufacturing Officer of ADIENNE and is also acting as the Company’s General Manager for Italy. He obtained an advanced degreee in Engineering at Politecnico di Milano in 1994 and has an over 20 years working experience in pharmaceutical manufacturing as Engineering Director at Bausch & Lomb and as Read more about Federico Sanvito, Chief Manufacturing Officer and General Manager ADIENNE SRL (Italy)[…]

Silvana Minoretti, Chief Financial Officer

Silvana Minoretti (born in 1963) is a member of the Board of Directors. She is a chartered financial analyst CFA®, certified accountant and a tax law expert. Furthermore, Silvana Minoretti is a member of the grand council of the Canton of Ticino, Tax commissioner, member of the board of the supervisory authority for trust service Read more about Silvana Minoretti, Chief Financial Officer[…]